Live audio webcasts of the two presentations may be accessed via the News and Events page of the Investor Relations section of the Amarantus corporate web site under the IR Calendar at www.amarantus.com. Webcast replays will be available approximately two hours after the presentation ends and will be archived for 30 days.

MANF Development Program Presentation
Date: Monday, January 12, 2015
Time: 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time
Presenter: Roman Urfer, Ph.D., Chief Development Officer at NeuroAssets


Brain Health and Neurological Diseases Panel
Date: Tuesday, January 13, 2015
Time: 3:00 - 3:45 p.m. Pacific Time / 6:00 - 6:45 p.m. Eastern Time
Participants: John Commissiong, Ph.D., Chief Scientific Officer

David Lowe, Ph.D., Member of the Amarantus Board of Directors


Eltoprazine Development Program Presentation
Date: Tuesday, January 13, 2015
Time: 4:20 p.m. Pacific Time / 7:20 p.m. Eastern Time
Presenter: Charlotte Keywood, M.D., Chief Medical Officer at Amarantus